HRTX
Heron TherapeutiNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$230.14M
P/E Ratio
—
EPS
$-0.12
Beta
1.71
52W High
$2.48
52W Low
$0.74
50-Day MA
$0.97
200-Day MA
$1.24
Dividend Yield
—
Profit Margin
-13.00%
Forward P/E
46.95
PEG Ratio
-0.18
About Heron Therapeuti
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $154.90M |
| Gross Profit (TTM) | $112.52M |
| EBITDA | -224,000 |
| Operating Margin | 0.09% |
| Return on Equity | -2409.00% |
| Return on Assets | -0.65% |
| Revenue/Share (TTM) | $0.93 |
| Book Value | $0.07 |
| Price-to-Book | 18.03 |
| Price-to-Sales (TTM) | 1.49 |
| EV/Revenue | 2.159 |
| EV/EBITDA | 35.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -0.50% |
| Shares Outstanding | $188.64M |
| Float | $133.67M |
| % Insiders | 0.86% |
| % Institutions | 84.15% |
Historical Volatility
HV 10-Day
98.67%
HV 20-Day
77.88%
HV 30-Day
74.15%
HV 60-Day
73.61%
HV Rank
73.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.33 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026